The aging process: where are the drug opportunities?
- 25 July 2000
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 4 (4) , 371-376
- https://doi.org/10.1016/s1367-5931(00)00104-6
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Ligand Activation Domain of Human Orphan Growth Hormone (GH) Secretagogue Receptor (GHS-R) Conserved from Pufferfish to HumansMolecular Endocrinology, 2000
- Identification of a Novel Aspartic Protease (Asp 2) as β-SecretaseMolecular and Cellular Neuroscience, 1999
- Reduced Nurrl Expression Increases the Vulnerability of Mesencephalic Dopamine Neurons to MPTP‐Induced InjuryJournal of Neurochemistry, 1999
- Impaired Cardiac Performance in Elderly Patients with Growth Hormone DeficiencyJournal of Clinical Endocrinology & Metabolism, 1999
- Growth Hormone-Independent Cardioprotective Effects of Hexarelin in the RatEndocrinology, 1999
- The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient PatientsJournal of Clinical Endocrinology & Metabolism, 1999
- Alternatives to the Use of Estrogen in Postmenopausal WomenEndocrine Reviews, 1999
- Nuclear Receptor Coregulators: Cellular and Molecular BiologyEndocrine Reviews, 1999
- Estrogen Actions in the Central Nervous SystemEndocrine Reviews, 1999
- A New Orphan Receptor Involved in Pulsatile Growth Hormone ReleaseTrends in Endocrinology & Metabolism, 1999